TranS1 Inc. to Present at the Canaccord Genuity Musculoskeletal Conference

/ Source: GlobeNewswire

WILMINGTON, N.C., Feb. 11, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the Canaccord Genuity Musculoskeletal Conference in San Diego, CA on Tuesday, February 15, 2011 at 10 a.m. PT.   Mr. Reali and Mr. Slattery will discuss the Company and its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region.

The presentation will be webcast live and may be accessed by visiting TranS1's website at . A replay of the webcast will also be available immediately after the conclusion of the presentation. Investors can access the webcast under the investor relations section of TranS1's website.

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single and multilevel lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion.  TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.

CONTACT: Investors: TranS1 Inc. Joseph P. Slattery, 910-332-1700 Executive Vice-President and Chief Financial Officer Westwicke Partners Mark Klausner, 443-213-0501 trans1@westwicke.com